A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma
Clinical trial NCT06318884 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06318884
- Sponsor
- Sinocelltech Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2026-10-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.